745 related articles for article (PubMed ID: 24623966)
1. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Hartnett ME
Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
[TBL] [Abstract][Full Text] [Related]
2. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.
Budd S; Byfield G; Martiniuk D; Geisen P; Hartnett ME
Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity.
Han X; Kong J; Hartnett ME; Wang H
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1604-1613. PubMed ID: 30995317
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
6. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.
McCloskey M; Wang H; Jiang Y; Smith GW; Strange J; Hartnett ME
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2020-6. PubMed ID: 23449716
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase 4-derived H2O2 promotes aberrant retinal neovascularization via activation of VEGF receptor 2 pathway in oxygen-induced retinopathy.
Li J; Wang JJ; Zhang SX
J Diabetes Res; 2015; 2015():963289. PubMed ID: 25866826
[TBL] [Abstract][Full Text] [Related]
8. VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis.
Yang Z; Wang H; Jiang Y; Hartnett ME
Am J Pathol; 2014 Apr; 184(4):1230-1239. PubMed ID: 24630601
[TBL] [Abstract][Full Text] [Related]
9. The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.
Byfield G; Budd S; Hartnett ME
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3360-5. PubMed ID: 19264880
[TBL] [Abstract][Full Text] [Related]
10. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
Jiang Y; Wang H; Culp D; Yang Z; Fotheringham L; Flannery J; Hammond S; Kafri T; Hartnett ME
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):824-31. PubMed ID: 24425851
[TBL] [Abstract][Full Text] [Related]
11. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079
[TBL] [Abstract][Full Text] [Related]
12. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.
Kim YM; Kim SJ; Tatsunami R; Yamamura H; Fukai T; Ushio-Fukai M
Am J Physiol Cell Physiol; 2017 Jun; 312(6):C749-C764. PubMed ID: 28424170
[TBL] [Abstract][Full Text] [Related]
13. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation.
Wang H; Han X; Wittchen ES; Hartnett ME
Mol Vis; 2016; 22():116-28. PubMed ID: 26900328
[TBL] [Abstract][Full Text] [Related]
14. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
Budd SJ; Hartnett ME
Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
16. Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Smith GW; Yang Z; Jiang Y; McCloskey M; Greenberg K; Geisen P; Culp WD; Flannery J; Kafri T; Hammond S; Hartnett ME
Am J Pathol; 2013 Sep; 183(3):964-74. PubMed ID: 23972394
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity.
Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME
Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.
Simmons AB; Bretz CA; Wang H; Kunz E; Hajj K; Kennedy C; Yang Z; Suwanmanee T; Kafri T; Hartnett ME
Angiogenesis; 2018 Nov; 21(4):751-764. PubMed ID: 29730824
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.
Li J; Wang JJ; Yu Q; Chen K; Mahadev K; Zhang SX
Diabetes; 2010 Jun; 59(6):1528-38. PubMed ID: 20332345
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Flannery J; Hammond S; Kafri T; Vemuri SK; Jones B; Hartnett ME
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):737-44. PubMed ID: 24425858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
